The Button Mushroom: A genuine innovation for Osteoarthritis treatment?
The button mushroom, commonly known for its culinary uses, is now emerging in a completely new light within the field of joint health. Thanks to an innovation from Belgian biotechnology, carboxymethyl-chitosan, derived from this mushroom, is now being utilized as a treatment for refractory osteoarthritis. As part of the 37th French Congress of Rheumatology, a roundtable organized by KiOmed Pharma and Arsylab will shed light on this breakthrough.
Why the Button Mushroom?
Refractory osteoarthritis, particularly of the knee, presents significant challenges for both practitioners and researchers. Traditional treatments are often limited and do not always meet patients’ needs. Carboxymethyl-chitosan, extracted from the button mushroom, represents an innovative solution: a biomaterial that, in the form of a liquid implant, works as a single injection to relieve persistent osteoarthritis symptoms.
This unique treatment will be presented during the roundtable by renowned experts in the fields of rheumatology, orthopedic surgery, physical rehabilitation, and sports medicine. Their goal? To explore the potential of carboxymethyl-chitosan and discuss its initial applications across diverse settings, from private rheumatology practice to sports medicine.
Roundtable Program
The program, structured around presentations by several experts and moderated by Professor Xavier Chevalier:
- Welcome and Introduction of Speakers
Professor Xavier Chevalier, Rheumatologist (Créteil)
- Introduction to Osteoarthritis and Focus on Phenotypes of Refractory Patients
Overview of osteoarthritis characteristics, patient phenotypes, and the challenges associated with refractory cases.
Professor Yves Henrotin, Professor of Pathology, Physical Therapy, and Rehabilitation (Liège)
- Review of Carboxymethyl-Chitosan Use in a Sports Center: Insights from a Surgeon and a Physical Medicine Specialist
Discussion on the applications of carboxymethyl-chitosan in a sports setting, with a focus on preliminary results from an ongoing study at the CUSA center.
Professor Thomas Neri, Orthopedic Surgeon (Saint-Étienne)
Dr. Caroline Perrin, Physical Rehabilitation and Sports Medicine Physician (Saint-Étienne)
- Integration of Carboxymethyl-Chitosan in Sports Medicine
Practical insights and experiences with carboxymethyl-chitosan in sports medicine, with real-world examples.
Dr. Claude Marblé, Sports Medicine Physician (Marseille)
- Carboxymethyl-Chitosan in Private Rheumatology Practice
Case-based insights into the use of carboxymethyl-chitosan in private rheumatology practice.
Dr. Henri Lellouche, Rheumatologist (Paris)
Dr. Mohammed Belmouhoub, Rheumatologist (Valence)
- Expert Discussion
Exchange between speakers, Q&A, and exploration of future perspectives for the use of carboxymethyl-chitosan in managing patients with refractory osteoarthritis.
Carboxymethyl-Chitosan in Practice: Perspectives and Case Studies
As an innovative implant, carboxymethyl-chitosan stands out for its ability to offer long-term symptom relief for patients with refractory osteoarthritis. During the roundtable, speakers will share their practical experience with this treatment in real-world settings.
Why Attend This Roundtable?
This roundtable offers a unique opportunity to gain firsthand insights from experts about this new innovation and its potential impact on the management of refractory osteoarthritis. It is open to all healthcare professionals, researchers, and decision-makers attending the 2024 SFR Congress.
📅 Date: Monday, December 9, 2024
🕒 Time: 11:10 AM – 12:10 PM
📍 Location: Room 9, Hall 7.3, Porte de Versailles, 37th French Congress of Rheumatology
To register, visit the SFR Congress website directly: https://congres.larhumatologie.fr/
For further questions, contact Fabrice Letimier at: fabrice.letimier@kiomedpharma.com
